Armis Advisers »

Regeneron Pharmaceuticals shares owned by Armis Advisers

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Armis Advisers from 13F filings

Historical chart of Armis Advisers investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Armis Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Armis Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $200k 312 642.30

More positions owned by Armis Advisers

Listed Fds Tr Shares Lag Cap (OVL)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Listed Fds Tr Overlay Shares (OVLH)
Vanguard Index Fds Growth Etf (VUG)
Listed Fds Tr Overlay Shs Shrt (OVT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard World Mega Cap Val Etf (MGV)

View all positions for Armis Advisers

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals